Home > Cashflow Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Cashflow Statement

NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATH BIOGENES (INDIA) Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Profit Before Tax₹41 Cr₹42 Cr₹36 Cr₹-63 Cr₹12 Cr
Adjustment ₹13 Cr₹10 Cr₹13 Cr₹102 Cr₹8.18 Cr
Changes In working Capital ₹-35 Cr₹23 Cr₹-9.81 Cr₹-19 Cr₹-5.72 Cr
Cash Flow after changes in Working Capital ₹19 Cr₹75 Cr₹39 Cr₹20 Cr₹15 Cr
Cash Flow from Operating Activities ₹18 Cr₹75 Cr₹38 Cr₹17 Cr₹14 Cr
Cash Flow from Investing Activities ₹-3.96 Cr₹-27 Cr₹-2.88 Cr₹-20 Cr₹-21 Cr
Cash Flow from Financing Activities ₹-2.13 Cr₹-7.78 Cr₹-1.67 Cr₹-22 Cr₹5.74 Cr
Net Cash Inflow / Outflow ₹11 Cr₹39 Cr₹34 Cr₹-25 Cr₹-0.81 Cr
Opening Cash & Cash Equivalents ₹77 Cr₹38 Cr₹4.18 Cr₹29 Cr₹3.29 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹89 Cr₹77 Cr₹38 Cr₹4.18 Cr₹2.48 Cr

Compare Cashflow Statement of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹276.5 Cr -2.6% -0.4% -10.1% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,384.5 Cr -1.4% 0.1% -4.1% Stock Analytics
KAVERI SEED COMPANY ₹4,178.7 Cr -4% -2.8% -10.3% Stock Analytics
VENKYS (INDIA) ₹1,938.8 Cr -3% -7.9% -16.6% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹967.1 Cr 0.2% -3.1% -34.6% Stock Analytics
INDO US BIOTECH ₹301.6 Cr 13% 30.2% -32.5% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-2.6%

-0.4%

-10.1%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses